undefined

undefined

27

2019

/

09

Food and Drug Administration Launches 2015 National Safe Drug Use Month

发布时间：2019-09-27

According to the requirements of the "National Food and Drug Safety Science Popularization Action Plan (2011-2015)", the "National Safe Drug Month" (hereinafter referred to as the "Safety Month") is held every September. In order to effectively carry out this year's safety month activities, relevant matters are hereby notified as follows:

06

2017

/

11

Wuhan Wuyao Pharmaceutical Co., Ltd. Cleaner Production Audit Information Announcement

发布时间：2017-11-06

Wuhan Wuyao Pharmaceutical Co., Ltd. Cleaner Production Audit Information Announcement Release Unit: Wuhan Wuyao Pharmaceutical Co., Ltd. First Release Date: November 6, 2017 According to the the People's Republic of China Cleaner Production Promotion Law, Cleaner Production Audit Measures and other relevant documents, the clean production compliance of Wuhan Wuyao Pharmaceutical Co., Ltd. and the basic information, pollutant emission and total amount control of enterprises in 2016 are hereby announced as follows, all sectors of society are requested to supervise the implementation of cleaner production audits by our company. 1. Project Name and Project Summary Project Name: Cleaner Production Audit of Wuhan Wuyao Pharmaceutical Co., Ltd.

09

2017

/

06

2017 CPHI CHINA Shanghai

发布时间：2017-06-09

From June 20 to 22, 2017, the 17th World Pharmaceutical Raw Materials China Exhibition (CPhI & BioPh China 2017) will join the 2017 World Pharmaceutical Contract Customization Service China Exhibition (ICSE China 2017), the 12th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (P-MEC & InnoPack China 2017) and the 2017 World Biochemical, Analytical Instruments and Laboratory Equipment China Exhibition (LABWorld China 2017), common structure

26

2017

/

04

API China China International Pharmaceutical Bulk Drug, Intermediate, Packaging and Equipment Fair

发布时间：2017-04-26

As the oldest exhibition in China's pharmaceutical field, API will be founded in 1968. After more than 40 years of development, the exhibits of the raw materials fair not only cover more than 50000 kinds of raw materials in 24 categories, but also include all auxiliary materials, functional ingredients, internal and external packaging materials, production and testing equipment needed for the production of medicine and health products. Today's raw materials fair has become a "one-stop" efficient industry platform for tens of thousands of pharmaceutical and health products manufacturers at home and abroad, providing an excellent opportunity for pharmaceutical colleagues at home and abroad to fully understand the development trend of China's pharmaceutical and health products industry, meet friends in the industry and discover new business opportunities. It is these unique charm

30

2016

/

06

CPhI China 2016

发布时间：2016-06-30

On June 21-23, 2016, the 16th World Pharmaceutical Raw Materials China Exhibition (CPhIChina2016) and the 11th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (P-MECChina2016) were grandly opened at Shanghai Pudong New International Expo Center. As a member of "China Yuanda Health", our company has cooperated with East China Pharmaceutical Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Hubei Yuanda Fuchi Pharmaceutical and Chemical Co., Ltd., Wuhan Yuanda Hongyuan Co., Ltd., Huanggang Fuchi Pharmaceutical Co., Ltd., Baoding Jiufu Biochemical Co., Ltd. and Jiangsu Yuanda.

25

2016

/

03

The results of the selection of "Outstanding Enterprise Brands and Product Brands in Hubei Pharmaceutical Industry in 2015" were announced. Yuanda Pharmaceutical and its member enterprises were selected.

发布时间：2016-03-25

A few days ago, the provincial government approved the "2015 Hubei Province pharmaceutical industry outstanding enterprise brand and product brand" selection results officially announced. In this selection, Broad Medicine won a total of 21 awards, including 6 corporate awards and 15 product awards. At the same time, Yuanda Pharmaceutical (China) Co., Ltd. was selected as one of the "Top Ten Pharmaceutical Manufacturers in Hubei Province in 2015" and ranked among the top three. Many products of the company and its member enterprises were selected as "excellent product brands of Hubei pharmaceutical industry in 2015".

01

2016

/

01

Fu Chi Industrial Park New Year's Day Celebration and Spring Festival Theme Party Held Ceremoniously

发布时间：2016-01-01

On the evening of December 28, 2015, the theme party of "making the present more future" to celebrate the new year's day and welcome the new year was held in Yuanda Medical Training School. Xie Guofan, chairman of the company, Zhang Guosheng, deputy general manager, Xiong Xiansheng, director of the park management committee, and others were present at the scene. The party was hosted by Yuanda Pharmaceutical Fuchi Industrial Park and co-hosted by Wuyao Pharmaceutical, Fuchi Chemical, Huanggang Pharmaceutical and Biological Company. Everyone gathered together, singing and dancing together to welcome the arrival of the New Year. At 18:30, the party kicked off with a song of "Great Song" sung by the whole audience. The singing brought good wishes to the company and the passion was loud and clear. The evening program is organized by members of all enterprises in the park.

26

2015

/

08

New Drug Classification Cited 3 Categories of Drug Imitation Change

发布时间：2015-08-26

The Opinions of the State Council on Reforming the Review and Approval System of Drugs and Medical Devices (No. 44 [2015] of the State Council) classifies drugs into two types: new drugs and generic drugs, and adjusts new drugs from the current "drugs that have not been marketed in China" to "drugs that have not been marketed in China", the generic drugs will be adjusted from the current "generic drugs with existing national standards" to "generic drugs with the same quality and efficacy as the original drugs". At present, the detailed new drug registration classification supporting plan is still in the pipeline, but the management of the drug classification re-adjustment, will undoubtedly lead to the traditional classification of three types of drugs into the generic drug model.

< 1...5678 >